The outcome of advanced chronic nephropathy in type 1 and type 2 diabetic and non-diabetic patients: A prospective study

Diabetes and Metabolism

Volumn 25, Issue 2, 1999, Pages 144-149

  Altman, J J ^a   Elian, N ^a   Grun, S ^a   Gerard, H G ^a   Feldman, S ^a  

^a Hopital Laennec   (France)

Author keywords

Arteriovenous fistula; Diabetes; Dialysis; Nephropathy; Vascular disease

Indexed keywords

CREATININE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; UREMIA;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; UREMIA;

EID: 0032782151     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Friedman EA. Clinical imperatives in diabetic nephropathy. Kidney Int, 1983, 23,16-19.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med, 1993, 329, 977-986.
3. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med, 1985, 78, 785-794.
4. Krolewski AS, Warram JH, Lawrence IR, Kahn CR. Epidemiological approach to the etiology of type I diabetes mellitus and its complications. N Eng J Med, 1987, 317, 1390-1398.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 16, 31-41.
6. Kleinknecht D, Bennis D, Altman JJ. Increased prevalence of non-diabetic renal pathology in type II diabetes mellitus. Nephrol Dial Transplant, 1992, 7(12), 1258-1259.
7. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda MD, National Institute of Health, National Heart, Lung, and Blood Institute, 1993.
8. Parving HH, Andersen AR, Smidt U, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet, 1983, 1(8335), 1175-1179.
9. Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H. Long-term correction of hyperglyceamia and progression of renal failure in insulin-dependent diabetes. Br Med J, 1983, 286, 598-601.
10. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the collaborative study group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med, 1993, 329, 1456-1464.
11. Cameron JS, Challah S. Treatment of end-stage renal failure due to diabetes in the United Kingdom, 1975-84, Lancet, 1986, 2(8513), 962-966.
12. Brunner FP, Brynger H, Challah S et al. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Nephrol Dial Transplant, 1988, 3, 585-595.
13. Jacobs C, Brunner FP, Brynger H et al. The first five thousand diabetics treated by dialysis and transplantation in Europe. In: Mogensen C. E., Jansen H. A., eds. "Diabetic Nephropathy". 1985, 5, 12-16.
14. Byrne C, Vernon P, Cohen JJ. Effect of age and diagnosis on survival of older patients beginning chronic dialysis. JAMA, 1994, 271, 34-36.
15. Koch M, Thomas B, Tschpe W, Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia, 1993, 36, 1113-1117.
16. Ritz E, Keller C, Bergis K, Strojek K. Pathogenesis and course of renal disease in IDDM/NIDDM: differences and similarities. Am J Hypertens, 1997, 10, 202S-207S.
17. Jones RH, Hayakawa H, Mackay JD, Parsons V, Watkins PJ. Progression of diabetic nephropathy. Lancet 1979, 1(8126), 1105-1106.
18. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J, 1982, 285, 685-688.
19. Nyberg G, Blohmé G, Norden G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia, 1987, 30, 82-86.
20. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia, 1991, 34, 164-170.
21. Altman JJ, Bazot M, Daniel F et al. Effect of tight control of glycemia and blood pressure in 34 patients with severe progressive nephropathy. Transplant Proc, 1986, 18, 1659-1660.
22. Klahr S, Levey AS, Beck GJ et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Eng J Med, 1994, 330, 877-884.
23. Pugh JA, Medina RA, Cornell JC, Basu S. NIDDM is the major cause of diabetic end-stage renal disease. Diabetes, 1995, 44, 1375-1380.
24. Bloomgarden ZT. Perspectives on the news, American Diabetes Association Scientific Sessions, 1995, Nephropathy. Diabetes Care, 1995, 18, 1402-1405.
25. Parving HH. Initiation and Progression of Diabetic Nephropathy. N Engl J Med, 1996, 335, 1682-1683.